Thereafter, we investigated the association between EGF+61 A>G genotype and TKI response in a Brazilian series comprised of 111 TKI‐treated lung adenocarcinoma patients harboring EGFR‐sensitizing mutations. Here, EGFR is linked to lung adenocarcinoma.